Ethan Basch
Impact in
- Oncology top 0.05%
- Cancer survivorship and care
- Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Treatment and Research
Papers in
- Oncology 197
- Cancer survivorship and care 180
-
- Statistical Methods in Clinical Trials 62
- Co-authors
- Deborah Schrag (37 shared papers)Howard I. Scher (23 shared papers)Mark G. Kris (18 shared papers)Amylou Constance Dueck (47 shared papers)Antonia Vickery Bennett (51 shared papers)Allison Mary Deal (36 shared papers)Catherine E. Ulbricht (55 shared papers)Clifford A. Hudis (7 shared papers)
- Journals
- Journal of Clinical Oncology (31 papers)JAMA (21 papers)The Lancet Oncology (17 papers)JAMA Oncology (17 papers)Quality of Life Research (15 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Ethan Basch
419 papers receiving 38.1k citations
Ethan Basch's Hit Papers
Peers
Comparison fields: 5 of 183
- Oncology 12.4k
- Pulmonary and Respiratory Medicine 8.1k
- General Health Professions 4.5k
- Geriatrics and Gerontology 598
- Toxicology 864
Countries citing papers authored by Ethan Basch
This map shows the geographic impact of Ethan Basch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan Basch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan Basch more than expected).
Fields of papers citing papers by Ethan Basch
This network shows the impact of papers produced by Ethan Basch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan Basch. The network helps show where Ethan Basch may publish in the future.
Co-authors
The 25 scholars most cited alongside Ethan Basch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 446 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy Hit paper breakdown → | 2012 | 2313 |
| 2 | Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial Hit paper breakdown → | 2015 | 1971 |
| 3 | Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group Hit paper breakdown → | 2008 | 1917 |
| 4 | Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment Hit paper breakdown → | 2017 | 1682 |
| 5 | Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2017 | 1602 |
| 6 | Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 Hit paper breakdown → | 2016 | 1313 |
| 7 | American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care Hit paper breakdown → | 2012 | 1072 |
| 8 | Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2011 | 901 |
| 9 | Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Hit paper breakdown → | 2014 | 901 |
| 10 | Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Hit paper breakdown → | 2015 | 834 |
| 11 | Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols Hit paper breakdown → | 2018 | 617 |
| 12 | 2006 | 563 | |
| 13 | 2009 | 539 | |
| 14 | The Missing Voice of Patients in Drug-Safety Reporting Hit paper breakdown → | 2010 | 528 |
| 15 | The PCORI Perspective on Patient-Centered Outcomes Research Hit paper breakdown → | 2014 | 467 |
| 16 | Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2017 | 460 |
| 17 | Patient-Reported Outcomes — Harnessing Patients’ Voices to Improve Clinical Care Hit paper breakdown → | 2017 | 454 |
| 18 | Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures: ISPOR ePRO Good Research Practices Task Force Report Hit paper breakdown → | 2008 | 445 |
| 19 | Therapeutic applications of fenugreek. | 2003 | 424 |
| 20 | Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology Hit paper breakdown → | 2012 | 409 |
About Ethan Basch
Ethan Basch is a scholar working on Oncology, Statistics and Probability, Complementary and alternative medicine, General Health Professions and Economics and Econometrics, having authored 446 papers that have together received 39.4k indexed citations. Recurring topics across this work include Cancer survivorship and care (180 papers), Statistical Methods in Clinical Trials (62 papers), Health Systems, Economic Evaluations, Quality of Life (38 papers), Prostate Cancer Treatment and Research (34 papers), Mobile Health and mHealth Applications (30 papers), Complementary and Alternative Medicine Studies (29 papers), Medicinal Plant Research (27 papers) and Electronic Health Records Systems (23 papers). The work is most often cited by research in Oncology (12.4k citations), Pulmonary and Respiratory Medicine (8.1k citations), General Health Professions (4.5k citations), Geriatrics and Gerontology (598 citations) and Toxicology (864 citations). Ethan Basch has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Deborah Schrag, Howard I. Scher, Mark G. Kris, Amylou Constance Dueck, Antonia Vickery Bennett, Allison Mary Deal, Catherine E. Ulbricht, Clifford A. Hudis, Thomas Michael Atkinson and Allison Barz Leahy. Their work appears in journals such as Journal of Clinical Oncology, JAMA, The Lancet Oncology, JAMA Oncology and Quality of Life Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.